aid: crispr-therapeutics accessModel: pricing: unknown onboarding: unknown trial: false try_now: false public: false label: Unknown confidence: low source: [] generated: '2026-07-22' method: derived image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/crispr-therapeutics.png name: CRISPR Therapeutics description: 'CRISPR Therapeutics (NASDAQ: CRSP) is a clinical-stage biotechnology company founded in 2013 and headquartered in Zug, Switzerland, with US operations in Boston, Massachusetts. Co-founded by CRISPR/Cas9 pioneer Emmanuelle Charpentier, the company develops transformative gene-based medicines for serious human diseases. Its programs span hemoglobinopathies, immuno-oncology, regenerative medicine, and in-vivo editing; its lead therapy CASGEVY (exagamglogene autotemcel), developed with Vertex Pharmaceuticals, is the first approved CRISPR/Cas9 gene-editing treatment for sickle cell disease and transfusion-dependent beta thalassemia. This is a corporate/investor web presence with no public developer program or API surface.' url: https://raw.githubusercontent.com/api-evangelist/crispr-therapeutics/refs/heads/main/apis.yml x-type: company x-source: vc-portfolio x-backed-by: - nea x-tier: stub x-tier-reason: portfolio-lead specificationVersion: '0.20' created: '2026-07-17' modified: '2026-07-18' tags: - Company - Life Sciences - Biotechnology - Gene Editing - CRISPR - Genomics - Pharmaceuticals apis: [] maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: DomainSecurity url: security/crispr-therapeutics-domain-security.yml - type: Website url: https://www.crisprtx.com - type: PrivacyPolicy url: https://crisprtx.com/about-us/privacy-policy - type: TermsOfService url: https://crisprtx.com/about-us/terms-and-conditions - type: Support url: https://crisprtx.com/about-us/contact x-enrichment: date: '2026-07-19' status: backfilled pass: local-v1 note: backfilled from .gitignore signal + verified work evidence